Detalles de la búsqueda
1.
Pharmacogenetic interactions of efavirenz or rifampin and isoniazid with levonorgestrel emergency contraception during treatment of HIV or tuberculosis.
Pharmacogenet Genomics
; 33(6): 126-135, 2023 08 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-37306344
2.
Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s.
Antimicrob Agents Chemother
; 67(11): e0073723, 2023 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-37882552
3.
Perspectives of people living with HIV and health workers about a point-of-care adherence assay: a qualitative study on acceptability.
AIDS Care
; 35(10): 1628-1634, 2023 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-36781407
4.
Clinical Experience With Severe Acute Respiratory Syndrome Coronavirus 2-Related Illness in Children: Hospital Experience in Cape Town, South Africa.
Clin Infect Dis
; 72(12): e938-e944, 2021 06 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33170927
5.
Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S8-S19, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645162
6.
Myocardial Steatosis Among Antiretroviral Therapy-Treated People With Human Immunodeficiency Virus Participating in the REPRIEVE Trial.
J Infect Dis
; 222(Suppl 1): S63-S69, 2020 07 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32645158
7.
Diverse Human Immunodeficiency Virus-1 Drug Resistance Profiles at Screening for ACTG A5288: A Study of People Experiencing Virologic Failure on Second-line Antiretroviral Therapy in Resource-limited Settings.
Clin Infect Dis
; 71(7): e170-e177, 2020 10 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-31724034
8.
Corrigendum to: Patterns of Antiretroviral Therapy Use and Immunologic Profiles at Enrollment in the REPRIEVE Trial.
J Infect Dis
; 223(2): 352, 2021 02 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33068427
9.
Under-representation of the WHO African region in clinical trials of interventions against hepatitis B virus infection.
Lancet Gastroenterol Hepatol
; 9(4): 383-392, 2024 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-38367632
10.
Barriers that prevent adults living with HBV infection from participating in clinical research: experience from South Africa.
J Virus Erad
; 9(1): 100317, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-36911657
11.
Progression and persistence of low-grade cervical squamous intraepithelial lesions in women living with human immunodeficiency virus.
J Low Genit Tract Dis
; 16(3): 243-50, 2012 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-22460273
12.
Urine tenofovir-monitoring predicts HIV viremia in patients treated with high genetic-barrier regimens.
AIDS
; 36(14): 2057-2062, 2022 11 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-36305182
13.
Drug Resistance, Rather than Low Tenofovir Levels in Blood or Urine, Is Associated with Tenofovir, Emtricitabine, and Efavirenz Failure in Resource-Limited Settings.
AIDS Res Hum Retroviruses
; 38(6): 455-462, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34779228
14.
A minimal monitoring approach for the treatment of hepatitis C virus infection (ACTG A5360 [MINMON]): a phase 4, open-label, single-arm trial.
Lancet Gastroenterol Hepatol
; 7(4): 307-317, 2022 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35026142
15.
Third-line antiretroviral therapy, including raltegravir (RAL), darunavir (DRV/r) and/or etravirine (ETR), is well tolerated and achieves durable virologic suppression over 144 weeks in resource-limited settings: ACTG A5288 strategy trial.
J Int AIDS Soc
; 25(6): e25905, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-36039892
16.
Antiretroviral hair levels, self-reported adherence, and virologic failure in second-line regimen patients in resource-limited settings.
AIDS
; 35(9): 1439-1449, 2021 07 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33831905
17.
Treatment advantage in HBV/HIV coinfection compared to HBV monoinfection in a South African cohort.
J Infect
; 81(1): 121-130, 2020 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-32360882
18.
Evidence of tenofovir resistance in chronic hepatitis B virus (HBV) infection: An observational case series of South African adults.
J Clin Virol
; 129: 104548, 2020 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663786
19.
Brief Report: Sex Differences in Outcomes for Individuals Presenting for Third-Line Antiretroviral Therapy.
J Acquir Immune Defic Syndr
; 84(2): 203-207, 2020 06 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32049773
20.
Third-line antiretroviral therapy in low-income and middle-income countries (ACTG A5288): a prospective strategy study.
Lancet HIV
; 6(9): e588-e600, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31371262